Klin Monbl Augenheilkd 2015; 232(4): 595-598
DOI: 10.1055/s-0034-1396328
Kasuistik
Georg Thieme Verlag KG Stuttgart · New York

Presentation and Outcome of a Cluster of Patients with Endogenous Endophthalmitis: A Case Series

Präsentation und Outcome einer Fallserie von endogenen Endophthalmitiden
J. Guber
1   Sutton Eye Unit, Epsom and St. Helier University Hospitals, NHS Trust (Lead Clinician: Miss Jane Leitch), London, UK
2   Bristol Eye Hospital, University Hospital Bristol (Lead Clinician: Mr Richard Markham), Bristol, UK
,
M. U. Saeed
1   Sutton Eye Unit, Epsom and St. Helier University Hospitals, NHS Trust (Lead Clinician: Miss Jane Leitch), London, UK
› Author Affiliations
Further Information

Publication History

Publication Date:
22 April 2015 (online)

Abstract

Background: The aim of this study was to investigate the clinical features and visual acuity outcomes associated with endogenous endophthalmitis. Material and Methods: Seven eyes of 6 patients treated at Epsom and St Helier University Hospitals between 2010 and 2013 were reviewed for endogenous endophthalmitis. Results: Patients were followed for a mean of 7 months (range 1 to 13). Positive blood cultures were obtained in 5 patients (83 %), including 1 patient with fungal isolates (17 %), two patients with Gram-positive isolates and another two with Gram-negative isolates. Five patients (83 %) were hospitalized at the time of diagnosis and 2 patients (33 %) died within 6 months of diagnosis. Initial treatment included vitreous tap and injection of intravitreal antibiotics. Only in one eye (14 %) were positive results from the biopsy obtained. Four eyes (57 %) achieved a final visual acuity of > 6/60. Patients with a Klebsiella endophthalmitis had worse visual outcome. Conclusions: Endogenous endophthalmitis is generally associated with high mortality and poor visual acuity outcomes. Gram-negative species are associated with poorer visual acuity. Vitreous biopsy has a weak diagnostic relevance as is it often negative.

Zusammenfassung

Hintergrund: Retrospektive Evaluation einer Fallserie von endogenen Endophthalmitiden. Material und Methoden: Analysiert wurden 7 Augen von 6 konsekutiven Patienten, die mit einer endogenen Endophthalmitis zwischen 2010 und 2013 behandelt wurden. Ergebnisse: Die Follow-up Zeit betrug im Durchschnitt 7 Monate. Insgesamt 5 Patienten (83 %) hatten eine positive Blutkultur: bei einem Patient wurde Candida gefunden (17 %), bei je 2 Patienten (33 %) wurden grampositive beziehungsweise gramnegative Erreger isoliert. Zwei Patienten (33 %) starben innerhalb von 6 Monaten nach Diagnosestellung. Bei allen Augen wurde eine Aspirationsbiopsie des Glaskörpers durchgeführt sowie gleichzeitig Antibiotika intravitreal verabreicht. Nur bei einem Auge (14 %) konnte ein positives Resultat gewonnen werden. 4 Augen (57 %) erreichten nach der Behandlung eine Sehschärfe von > 6/60. Patienten mit einer Klebsiellen-Infektion hatten, verglichen mit den übrigen Patienten, einen deutlich schlechteren Visus. Schlussfolgerungen: Endogene Endophthalmitiden sind in der Regel mit hoher Sterblichkeit und schlechtem Endvisus verbunden. Infektionen mit gramnegativen Erregern sind mit einem schlechteren Visus behaftet. Die Nadelaspirationsbiopsie hat einen geringen diagnostischen Wert, da sie häufig negativ ausfällt.

 
  • References

  • 1 Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol 2001; 12: 464-470
  • 2 Shrader SK, Band JD, Lauter CB et al. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990; 162: 115-120
  • 3 Okada AA, Johnson RP, Liles WC et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994; 101: 832-838
  • 4 Valluri S, Moorthy RS, Liggett PE et al. Endogenous Aspergillus endophthalmitis in an immunocompetent individual. Int Ophthalmol 1993; 17: 131-135
  • 5 Jackson TL, Eykyn SJ, Graham EM et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003; 48: 403-423
  • 6 Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005; 25: 746-750
  • 7 Yoon YH, Lee SU, Sohn JH et al. Result of early vitrectomy for endogenous Klebsiella pneumonia endophthalmitis. Retina 2003; 23: 366-370
  • 8 Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 2009; 17: 148-152
  • 9 Scott IU, Matharoo N, Flynn jr. HW et al. Endophthalmitis caused by Klebsiella species. Am J Ophthalmol 2004; 138: 662-663
  • 10 Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479-1496
  • 11 Scott IU, Matharoo N, Flynn jr. HW et al. Endophthalmitis caused by Klebsiella species. Am J Ophthalmol 2004; 138: 662-663
  • 12 Sng CC, Jap A, Chan YH et al. Risk factors for endogenous Klebsiella endophthalmitis in patients with Klebsiella bacteraemia: a case-control study. Br J Ophthalmol 2008; 92: 673-677
  • 13 Binder MI, Chua J, Kaiser PK et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003; 82: 97-105
  • 14 Jackson TL, Eykyn SJ, Graham EM et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003; 48: 403-423
  • 15 Han DP, Wisniewski SR, Kelsey SF et al. Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 1999; 19: 98-102
  • 16 Schiedler V, Scott IU, Flynn jr. HW et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004; 137: 725-731
  • 17 Yoon YH, Lee SU, Sohn JH et al. Result of early vitrectomy for endogenous Klebsiella pneumonia endophthalmitis. Retina 2003; 23: 366-370
  • 18 Okhravi N, Towler HM, Hykin P et al. Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. Br J Ophthalmol 1997; 81: 719-725